Targeted retroviral vectors displaying a cleavage site-engineered hemagglutinin (HA) through HA–protease interactions
Open Access
- 30 November 2006
- journal article
- Published by Elsevier BV in Molecular Therapy
- Vol. 14 (5), 735-744
- https://doi.org/10.1016/j.ymthe.2006.04.007
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Endosomal Proteolysis of the Ebola Virus Glycoprotein Is Necessary for InfectionScience, 2005
- Roles of a conserved proline in the internal fusion peptide of Ebola glycoproteinFEBS Letters, 2004
- Targeting the cytotoxicity of fusogenic membrane glycoproteins in gliomas through protease–substrate interactionGene Therapy, 2003
- Relationship between SU Subdomains That Regulate the Receptor-Mediated Transition from the Native (Fusion-Inhibited) to the Fusion-Active Conformation of the Murine Leukemia Virus GlycoproteinJournal of Virology, 2002
- Lentiviral vectors pseudotyped with a modified RD114 envelope glycoprotein show increased stability in sera and augmented transduction of primary lymphocytes and CD34+ cells derived from human and nonhuman primatesBlood, 2002
- Evidence for nonspecific adsorption of targeted retrovirus vector particles to cellsGene Therapy, 2001
- Modification of retroviral tropism by display of IGF-IJournal of Molecular Biology, 1999
- Similar Structural Models of the Transmembrane Proteins of Ebola and Avian Sarcoma VirusesCell, 1996
- Structure of influenza haemagglutinin at the pH of membrane fusionNature, 1994
- Expression of Glial and Vimentin Type Intermediate Filaments in Cultures Derived from Human Glial MaterialDifferentiation, 1981